US Broker Ratings

Embecta Corp. (EMBC) Investor Outlook: Navigating Challenges with a Strategic Focus on Diabetes Solutions

Embecta Corp. (NASDAQ: EMBC), a noteworthy player in the healthcare sector, is navigating the medical instruments and supplies industry with a specialized focus on diabetes care...

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Gem with 74.59% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS), a pioneering name in the biotechnology sector, presents a compelling investment opportunity with a potential upside of 74.59%. As a clinical-stage..

Personalis, Inc. (PSNL) Stock Analysis: A Bold Bet in Cancer Genomics with a 30% Revenue Surge

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector specializing in diagnostics and research, is making waves with its innovative cancer genomic solutions. Headquartered..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a Potential 62.78% Upside

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with a promising outlook for investors...

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 24.41% Upside Potential in the Healthcare Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialized player in the healthcare sector, is capturing investor attention with its promising portfolio focused on rare disease treatments. Based..

Septerna, Inc. (SEPN) Investor Outlook: Strong Buy Ratings Signal 37% Potential Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company headquartered in South San Francisco, is making waves in the healthcare sector, specifically in biotechnology. With a market..

Autolus Therapeutics plc (AUTL) Stock Analysis: A Biotech Pioneer with a Staggering 354% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside of 354.43%, as per the..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 92.73% Potential Upside for Investors

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the healthcare sector under the drug manufacturers – specialty & generic industry, presents an intriguing opportunity for..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 729.88% Potential Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company at the forefront of developing innovative treatments for central nervous system (CNS) disorders, presents a captivating opportunity..

Altimmune, Inc. (ALT) Stock Analysis: Biotech’s Potential 431.55% Upside Draws Investor Attention

Altimmune, Inc. (NASDAQ: ALT), a Gaithersburg, Maryland-based biotechnology firm, has caught the eye of the investment community with its promising advancements in the healthcare sector. Specializing..

MeiraGTx Holdings (MGTX) Stock Analysis: Unveiling a 125% Upside Potential for Investors

MeiraGTx Holdings plc (NASDAQ: MGTX) stands out in the biotechnology sector with a robust growth trajectory and promising clinical trials that have caught the attention of..

AxoGen, Inc. (AXGN) Stock Analysis: Healthcare Innovator with a 19% Potential Upside

AxoGen, Inc. (NASDAQ: AXGN), a trailblazer in the medical devices sector, is capturing the attention of investors with a promising potential upside of 19.02%. Headquartered in..

Maravai LifeSciences Holdings (MRVI): Investor Outlook Reveals 2% Potential Upside Amidst Industry Growth

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a key player in the biotechnology sector, is capturing investor attention with its promising role in the ever-evolving healthcare landscape...

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Capturing a Potential 181.61% Upside in the Biotech Sector

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is making waves in the biotechnology industry, with its innovative approach to targeting G protein coupled receptors (GPCRs). Headquartered in Watertown,..

Valneva SE (VALN) Stock Analysis: Exploring an 86.45% Potential Upside in the Biotech Sector

Valneva SE (VALN), a prominent player in the biotechnology sector, commands attention with its strategic focus on developing and commercializing vaccines for infectious diseases with unmet..

Sana Biotechnology, Inc. (SANA) Investor Outlook: A Biotech Player with a 171.89% Upside Potential

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing attention in the biotechnology sector with its bold ambition to revolutionize cell-based therapies. With a market capitalization of $928.02..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring a Potential 549% Upside for Investors

In the realm of biotechnology, EyePoint, Inc. (NASDAQ: EYPT) stands out with a compelling narrative for investors eyeing substantial growth potential. With a market capitalization of..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 39% Upside in the Healthcare Sector

Bioventus Inc. (NASDAQ: BVS) is garnering attention in the healthcare sector with a compelling growth narrative and a promising outlook in the medical devices industry. Headquartered..

CareDx, Inc. (CDNA) Investor Outlook: Riding High with a 52.20% Revenue Growth in the Healthcare Sector

CareDx, Inc. (CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with a remarkable 52.20% revenue growth. Based..

AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a 10.43% Potential Upside in the Biotech Arena

AtaiBeckley Inc. (NASDAQ: ATAI) is a clinical-stage biopharmaceutical company that has caught the attention of investors with its innovative approach to mental health treatment. As a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds